{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:11:32Z","timestamp":1793848292479,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074479"],"award-info":[{"award-number":["82074479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is an endocrinological and metabolic disorder that can lead to female infertility. Lipid metabolomics and proteomics are the new disciplines in systems biology aimed to discover metabolic pathway changes in diseases and diagnosis of biomarkers. This study aims to reveal the features of PCOS to explore its pathogenesis at the protein and metabolic level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected follicular fluid samples and granulosa cells of women with PCOS and normal women who underwent in vitro fertilization(IVF) and embryo transfer were recruited. The samples were for the lipidomic study and the proteomic study based on the latest metabolomics and proteomics research platform.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lipid metabolomic analysis revealed abnormal metabolism of glycerides, glycerophospholipids, and sphingomyelin in the FF of PCOS. Differential lipids were strongly linked with the rate of high-quality embryos. In total, 144 differentially expressed proteins were screened in ovarian granulosa cells in women with PCOS compared to controls. Go functional enrichment analysis showed that differential proteins were associated with blood coagulation and lead to follicular development disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results showed that the differential lipid metabolites and proteins in PCOS were closely related to follicle quality,which can be potential biomarkers for oocyte maturation and ART outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-024-05167-x","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:02:51Z","timestamp":1713351771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"9","key":"5167_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"5167_CR2","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562\u20139.","journal-title":"Hum Reprod"},{"issue":"10","key":"5167_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrendo.2014.102","volume":"10","author":"CN Jayasena","year":"2014","unstructured":"Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10(10):624\u201336.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"5167_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1471-0528.2000.tb11644.x","volume":"107","author":"CJG Kelly","year":"2000","unstructured":"Kelly CJG, et al. The long term health consequences of polycystic ovary syndrome. BJOG. 2000;107(11):1327\u201338.","journal-title":"BJOG"},{"issue":"5","key":"5167_CR5","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"L Sun","year":"2012","unstructured":"Sun L, et al. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012;11(5):2937\u201346.","journal-title":"J Proteome Res"},{"key":"5167_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","volume":"448","author":"W Wang","year":"2015","unstructured":"Wang W, et al. Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS. Clin Chim Acta. 2015;448:39\u201347.","journal-title":"Clin Chim Acta"},{"key":"5167_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","volume":"13","author":"F Guo","year":"2022","unstructured":"Guo F, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in chinese population. Front Endocrinol. 2022;13: 892125.","journal-title":"Front Endocrinol"},{"issue":"6","key":"5167_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","volume":"58","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem. 2012;58(6):999\u20131009.","journal-title":"Clin Chem"},{"issue":"8","key":"5167_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4103\/0366-6999.229899","volume":"131","author":"Y Zou","year":"2018","unstructured":"Zou Y, et al. Identification of potential biomarkers for urine metabolomics of polycystic ovary syndrome based on gas chromatography-mass spectrometry. Chin Med J. 2018;131(8):945\u20139.","journal-title":"Chin Med J"},{"issue":"1","key":"5167_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","volume":"17","author":"Z Sun","year":"2019","unstructured":"Sun Z, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reprod Biol Endocrinol. 2019;17(1):45.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"5167_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/jrf.0.0370189","volume":"37","author":"RG Edwards","year":"1974","unstructured":"Edwards RG. follicular fluid. Reproduction. 1974;37(1):189\u2013219.","journal-title":"Reproduction"},{"issue":"2","key":"5167_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1210\/jc.2014-2086","volume":"100","author":"AS Ambekar","year":"2015","unstructured":"Ambekar AS, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"5167_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","volume":"185","author":"L Liu","year":"2019","unstructured":"Liu L, et al. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients. J Steroid Biochem Mol Biol. 2019;185:142\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"5167_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7827-4-19","volume":"4","author":"FH Thomas","year":"2006","unstructured":"Thomas FH, Vanderhyden BC. Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol. 2006;4(1):19.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"5167_CR15","first-page":"527","volume":"13","author":"X Ma","year":"2007","unstructured":"Ma X, et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. MHR. 2007;13(8):527\u201335.","journal-title":"MHR"},{"issue":"9","key":"5167_CR16","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1021\/pr100008e","volume":"9","author":"D Choi","year":"2010","unstructured":"Choi D, et al. The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis. J Proteome Res. 2010;9(9):4329\u201336.","journal-title":"J Proteome Res"},{"issue":"3","key":"5167_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/REP-16-0359","volume":"153","author":"B Wang","year":"2017","unstructured":"Wang B, et al. Decreased levels of sRAGE in follicular fluid from patients with PCOS. Reproduction. 2017;153(3):285\u201392.","journal-title":"Reproduction"},{"issue":"1\u20132","key":"5167_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2013.02.009","volume":"370","author":"M Insenser","year":"2013","unstructured":"Insenser M, et al. Proteomic and metabolomic approaches to the study of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;370(1\u20132):65\u201377.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"5167_CR19","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1210\/jc.2015-2566","volume":"100","author":"E Gourgari","year":"2015","unstructured":"Gourgari E, et al. Lipoprotein particles in adolescents and young women with PCOS provide insights into their cardiovascular risk. J Clin Endocrinol Metab. 2015;100(11):4291\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5167_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1262\/jrd.20103","volume":"55","author":"S Okawara","year":"2009","unstructured":"Okawara S, Hamano S, Tetsuka M. Bovine oocytes and early embryos express mRNA encoding glycerol kinase but addition of glycerol to the culture media interferes with oocyte maturation. J Reprod Dev. 2009;55(2):177\u201382.","journal-title":"J Reprod Dev"},{"issue":"4","key":"5167_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","volume":"54","author":"IR Pirwany","year":"2001","unstructured":"Pirwany IR, et al. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol. 2001;54(4):447\u201353.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"5167_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","volume":"113","author":"K Lauber","year":"2003","unstructured":"Lauber K, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003;113(6):717\u201330.","journal-title":"Cell"},{"issue":"49","key":"5167_CR23","doi-asserted-by":"publisher","first-page":"33833","DOI":"10.1074\/jbc.M109.024869","volume":"284","author":"K Yea","year":"2009","unstructured":"Yea K, et al. Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes. J Biol Chem. 2009;284(49):33833\u201340.","journal-title":"J Biol Chem"},{"key":"5167_CR24","unstructured":"Hannun, Y.A., et al., Basics of\u00a0Sphingolipid Metabolism and\u00a0Signalling, in Bioactive Sphingolipids in Cancer Biology and Therapy, Y.A. Hannun, et al., Y.A. Hannun, et al.^Editors. 2015, Springer International Publishing AG: Switzerland. p. 1\u201320."},{"key":"5167_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.plipres.2014.01.002","volume":"54","author":"J Ecker","year":"2014","unstructured":"Ecker J, Liebisch G. Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and sphingolipid species. Prog Lipid Res. 2014;54:14\u201331.","journal-title":"Prog Lipid Res"},{"issue":"9","key":"5167_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020\u20135.","journal-title":"Nat Genet"},{"issue":"4","key":"5167_CR27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1210\/jc.2010-2279","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5s-Holm L, et al. Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2011;96(4):1068\u201376.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5167_CR28","first-page":"314","volume":"43","author":"G Boutzios","year":"2013","unstructured":"Boutzios G, Karalaki M, Zapanti E. Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility Endocrine. 2013;43(2):314\u20137.","journal-title":"Impact on fertility Endocrine"},{"issue":"5","key":"5167_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.fertnstert.2004.04.048","volume":"82","author":"IY J\u00e4rvel\u00e4","year":"2004","unstructured":"J\u00e4rvel\u00e4 IY, et al. Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography. Fertil Steril. 2004;82(5):1358\u201363.","journal-title":"Fertil Steril"},{"issue":"1","key":"5167_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000706","volume":"3","author":"MM Aye","year":"2014","unstructured":"Aye MM, et al. Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome. J Am Heart Assoc. 2014;3(1): e000706.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"5167_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/ijmm.2013.1250","volume":"31","author":"Y Kim","year":"2013","unstructured":"Kim Y, et al. Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome. Int J Mol Med. 2013;31(3):707\u201316.","journal-title":"Int J Mol Med"},{"issue":"3","key":"5167_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1507\/endocrj.EJ18-0506","volume":"67","author":"C Tang","year":"2020","unstructured":"Tang C, et al. Association between circulating zinc-\u03b12-glycoprotein levels and the different phenotypes of polycystic ovary syndrome. Endocr J. 2020;67(3):249\u201355.","journal-title":"Endocr J"},{"issue":"1","key":"5167_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12944-018-0725-5","volume":"17","author":"R Zhang","year":"2018","unstructured":"Zhang R, et al. Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome. Lipids Health Dis. 2018;17(1):77.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"5167_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/09513590.2016.1223286","volume":"33","author":"G Sahin Ersoy","year":"2017","unstructured":"Sahin Ersoy G, et al. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile. Gynecol Endocrinol. 2017;33(2):119\u201323.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"5167_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12974-018-1132-6","volume":"15","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Overexpression of zinc-\u03b12-glycoprotein suppressed seizures and seizure-related neuroflammation in pentylenetetrazol-kindled rats. J Neuroinflammation. 2018;15(1):92.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5167_CR36","doi-asserted-by":"publisher","first-page":"25934","DOI":"10.1038\/srep25934","volume":"6","author":"Y Lai","year":"2016","unstructured":"Lai Y, et al. Circulating Zinc-\u03b12-glycoprotein levels and insulin resistance in polycystic ovary syndrome. Sci Rep. 2016;6(1):25934.","journal-title":"Sci Rep"},{"issue":"2","key":"5167_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/medicina57020100","volume":"57","author":"M Mirr","year":"2021","unstructured":"Mirr M, Owecki M. An update to the WISP-1\/CCN4 role in obesity, insulin resistance and diabetes. Medicina. 2021;57(2):100.","journal-title":"Medicina"},{"issue":"1","key":"5167_CR38","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41598-017-01866-2","volume":"7","author":"N Ferrand","year":"2017","unstructured":"Ferrand N, et al. WISP1\/CCN4 inhibits adipocyte differentiation through repression of PPAR\u03b3 activity. Sci Rep. 2017;7(1):1749.","journal-title":"Sci Rep"},{"issue":"2","key":"5167_CR39","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2019.03.011","volume":"221","author":"Y He","year":"2019","unstructured":"He Y, et al. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol. 2019;221(2):138.e1-138.e12.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05167-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:07:03Z","timestamp":1713352023000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05167-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Nanjing Medical University Ethics Committee authorized our experimental plan(Ethics No. 2022NL-200-03). All the research participants signed the informed consent of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}